Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of propofol vs cyclopol combined with remifentanil for painless bronchoscopy
ChiCTR2400081603Phase 4Not yet recruiting
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- Mar 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of propofol, ciprofol and remifentanil in pulmonary diseases (2 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoints: Oxygen saturation, Blood pressure and 2 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
propofolciprofolremifentanil
03
Conditions
pulmonary diseases
Beyond the preview
Go deeper on ChiCTR2400081603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081603.